At age 61 Francisco was diagnosed with prostate cancer with a Gleason 6. He saw various specialists who each recommended a different treatment. Francisco, an engineer, carefully educated himself about his options, finally choosing active surveillance. At his HMO, Francisco attended regular support group meetings but found the HMO highly resistant to active surveillance. Francisco recalls his travails with his HMO and how they finally came around to endorsing active surveillance.